[go: up one dir, main page]

CN105194740B - A kind of post-operation adhesion preventing hydrogel and preparation method thereof - Google Patents

A kind of post-operation adhesion preventing hydrogel and preparation method thereof Download PDF

Info

Publication number
CN105194740B
CN105194740B CN201510598128.7A CN201510598128A CN105194740B CN 105194740 B CN105194740 B CN 105194740B CN 201510598128 A CN201510598128 A CN 201510598128A CN 105194740 B CN105194740 B CN 105194740B
Authority
CN
China
Prior art keywords
mass ratio
powder
acrylamide monomer
sodium alginate
chitosan
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN201510598128.7A
Other languages
Chinese (zh)
Other versions
CN105194740A (en
Inventor
贺金梅
程凤
栗洪彬
黄玉东
刘长瑜
李纪伟
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Harbin Institute of Technology Shenzhen
Original Assignee
Harbin Institute of Technology Shenzhen
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Harbin Institute of Technology Shenzhen filed Critical Harbin Institute of Technology Shenzhen
Priority to CN201510598128.7A priority Critical patent/CN105194740B/en
Publication of CN105194740A publication Critical patent/CN105194740A/en
Application granted granted Critical
Publication of CN105194740B publication Critical patent/CN105194740B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Materials For Medical Uses (AREA)

Abstract

本发明公开了一种术后防粘连水凝胶及其制备方法,所述水凝胶由海藻酸钠粉末、壳聚糖粉末、丙烯酰胺单体、N,N’‑亚甲基双丙烯酰胺、硫酸钙、过硫酸胺和N,N,N’N’‑四甲基乙二胺制备而成。本发明提供了一种高强、高韧性壳聚糖与海藻酸钠复合水凝胶的制备方法,该制备方法易于操作,参数可控,材料易得,溶剂无毒或低毒,处理和使用安全;该方法集结了两种天然生物材料的优点,能够很好的满足预防患者术后防粘连的要求,及医护人员的护理治疗需求。该水凝胶柔软易于与皮肤贴合,具有良好的柔韧性,可以有效防止创面粘连,并能够被降解吸收,避免二次创伤的产生,有望成为新型术后防粘连材料。The invention discloses a postoperative anti-adhesion hydrogel and a preparation method thereof. The hydrogel is composed of sodium alginate powder, chitosan powder, acrylamide monomer, N,N'-methylenebisacrylamide , calcium sulfate, ammonium persulfate and N,N,N'N'-tetramethylethylenediamine. The invention provides a preparation method of a high-strength, high-toughness chitosan and sodium alginate composite hydrogel, the preparation method is easy to operate, the parameters are controllable, the material is easy to obtain, the solvent is non-toxic or low-toxic, and it is safe to handle and use ; This method combines the advantages of two natural biological materials, which can well meet the requirements of preventing postoperative anti-adhesion of patients and the nursing and treatment needs of medical staff. The hydrogel is soft and easy to adhere to the skin, has good flexibility, can effectively prevent wound adhesion, and can be degraded and absorbed to avoid secondary trauma. It is expected to become a new type of postoperative anti-adhesion material.

Description

一种术后防粘连水凝胶及其制备方法Postoperative anti-adhesion hydrogel and preparation method thereof

技术领域technical field

本发明属于生物医用材料技术领域,涉及一种具有术后防粘连、抗菌、止血、愈创作用的医用水凝胶及其制备方法。The invention belongs to the technical field of biomedical materials, and relates to a medical hydrogel with postoperative anti-adhesion, antibacterial, hemostatic and healing functions and a preparation method thereof.

背景技术Background technique

手术后粘连是有手术史以来国内外亟待解决的重要医学难题之一。在外科领域开展的手术中,绝大多数都涉及到防止组织之间粘连的问题,粘连发生不仅会给患者带来痛苦而且需面临高额的手术开销,因此开发预防粘连材料刻不容缓。在正常情况下,结缔组织的纤维带是不会与相邻的器官或组织粘在一起,但经手术后,因手术创伤、伤口局部缺血、异物存在、出血和暴露伤口表面及细菌感染而出现结缔组织纤维带与相邻组织或器官粘在一起的异常结构,也是在外科领域常见的临床现象—粘连。手术后粘连可以引起严重的并发症,如腹部、盆腔等均可引起粘连性肠梗阻,甲状腺手术后引起喉返神经损伤以及因盆腔组织粘连而导致的女性不育症。其中,做过腹腔手术的患者约有93%会有粘连发生,而经历过妇科手术的患者粘连的发生率高达97%(不孕妇女中40%是由粘连引起的)。因此,如何有效预防术后粘连来降低临床并发症的发生率是临床治疗中亟待解决的重要课题。Postoperative adhesion is one of the important medical problems to be solved urgently at home and abroad since the history of surgery. Most of the operations in the surgical field involve the prevention of adhesion between tissues. The occurrence of adhesion will not only bring pain to patients but also face high surgical expenses. Therefore, it is urgent to develop adhesion prevention materials. Under normal circumstances, the fibrous bands of connective tissue will not stick together with adjacent organs or tissues, but after surgery, due to surgical trauma, wound ischemia, foreign body presence, bleeding and exposed wound surface and bacterial infection Abnormal structures in which fibrous bands of connective tissue stick together with adjacent tissues or organs are also common clinical phenomena in the field of surgery—adhesions. Postoperative adhesions can cause serious complications, such as adhesive ileus in the abdomen and pelvis, recurrent laryngeal nerve injury after thyroid surgery, and female infertility caused by pelvic tissue adhesions. Among them, about 93% of patients who have undergone abdominal surgery will have adhesions, and the incidence of adhesions in patients who have undergone gynecological surgery is as high as 97% (40% of infertile women are caused by adhesions). Therefore, how to effectively prevent postoperative adhesions to reduce the incidence of clinical complications is an important issue to be solved in clinical treatment.

目前临床上应用较多的防术后粘连材料主要有凝胶类和聚乳酸类两种:凝胶类(透明质酸钠和壳聚糖凝胶)在体内能够生物降解,但降解速率过快,体内保留时间过短而且凝胶容易流失,使得防粘连效果欠佳;聚乳酸类(左旋聚乳酸、消旋聚乳酸等)是目前在生物医学工程应用最多的材料,同时也是通过美国FDA认证的为数不多的几种生物材料之一,但是其在降解过程中会产生酸性降解产物,酸性物质一方面起自催化作用、加速母体的降解,减少了体内保留时间,降低了防粘连效果,另一方面大量酸性产物堆积,又可能产生非感染性炎症对组织和器官造成一定的刺激。海藻酸钠具有良好的生物相容性、生物可降解性、止血性等生物性能,目前作为防粘连材料的报道较少。理想的防粘连材料应具有良好的生物相容性、适宜的组织粘附性(不需缝合),能完全覆盖创伤表面并具有足够的体内存留时间;能够降解吸收而不需二次手术将其取出;起到有效防止粘连形成的作用,又可以不影响伤口的正常愈合过程;同时兼顾止血、抗菌、促愈的作用并有一定的机械强度及韧性,以便于手术中将材料植入等。At present, there are mainly two types of postoperative adhesion prevention materials used clinically: gel and polylactic acid: gel (sodium hyaluronate and chitosan gel) can biodegrade in vivo, but the degradation rate is too fast , the retention time in the body is too short and the gel is easy to lose, which makes the anti-adhesion effect poor; polylactic acid (L-polylactic acid, racemic polylactic acid, etc.) is currently the most widely used material in biomedical engineering, and it is also certified by the US FDA It is one of the few biological materials, but it will produce acidic degradation products during the degradation process. On the one hand, acidic substances play an autocatalytic role, accelerate the degradation of the matrix, reduce the retention time in the body, and reduce the anti-adhesion effect. On the other hand, the accumulation of a large amount of acidic products may cause non-infectious inflammation and cause certain irritation to tissues and organs. Sodium alginate has good biocompatibility, biodegradability, hemostasis and other biological properties, and there are few reports on it as an anti-adhesion material. An ideal anti-adhesion material should have good biocompatibility, suitable tissue adhesion (no sutures required), be able to completely cover the wound surface and have sufficient retention time in the body; it can be degraded and absorbed without secondary surgery. Take it out; it can effectively prevent the formation of adhesions without affecting the normal healing process of the wound; at the same time, it also has the functions of hemostasis, antibacterial, and healing promotion, and has certain mechanical strength and toughness, so that the material can be implanted during the operation.

在已有专利中,CN 103224679A公开了一种壳聚糖聚丙烯酰胺水凝胶基底材料,由丙烯酰胺、甲叉双丙烯酰胺、过硫酸铵、四甲基乙二胺、壳聚糖等溶液组成,得到不同硬度的水凝胶且具有无毒性作用,降低了研究细胞力学的复杂性。CN 104558420A公开了一种温度和pH敏感性羧甲基壳聚糖水凝胶,分别以过硫酸铵、N,N,N’,N’-四甲基乙二胺和N,N’-亚甲基双丙烯酰胺为引发剂、促进剂和交联剂,通过交联反应制得,使得其生物相容性有所提高,扩大了其应用范围。CN 103396562A公开了一种基于海藻酸钠-丙烯酰胺水凝胶的制备方法,以丙烯酰胺单体、甲叉双丙烯酰胺为交联剂,过硫酸铵和N,N,N’,N’-四甲基乙二胺为催化剂,得到高强度、高韧性的海藻酸钠水凝胶。Li等制备的海藻酸盐-聚丙烯酰胺水凝胶可以同时具备高强度和韧性,采用丙烯酰胺、N,N’-亚甲基双丙烯酰胺、CaSO4·2H2O和CaCl2作为交联剂,过硫酸铵和N,N,N’,N’-四甲基乙二胺为催化剂制得的水凝胶,在生物医用领域具有很好的应用前景。Among the existing patents, CN 103224679A discloses a chitosan polyacrylamide hydrogel base material, which is composed of acrylamide, methylene bisacrylamide, ammonium persulfate, tetramethylethylenediamine, chitosan and other solutions Composition, to obtain hydrogels with different hardness and non-toxic effects, which reduces the complexity of studying cell mechanics. CN 104558420A discloses a temperature- and pH-sensitive carboxymethyl chitosan hydrogel, which is composed of ammonium persulfate, N,N,N',N'-tetramethylethylenediamine and N,N'-methylene The base bisacrylamide is used as an initiator, an accelerator and a crosslinking agent, and is prepared through a crosslinking reaction, which improves its biocompatibility and expands its application range. CN 103396562A discloses a preparation method based on sodium alginate-acrylamide hydrogel, using acrylamide monomer and methylenebisacrylamide as crosslinking agent, ammonium persulfate and N,N,N',N'- Tetramethylethylenediamine is used as a catalyst to obtain sodium alginate hydrogel with high strength and high toughness. The alginate-polyacrylamide hydrogel prepared by Li et al. can have high strength and toughness at the same time, using acrylamide, N,N'-methylenebisacrylamide, CaSO 4 2H 2 O and CaCl 2 as crosslinks agent, ammonium persulfate and N,N,N',N'-tetramethylethylenediamine as catalysts, the hydrogel has a good application prospect in the field of biomedicine.

发明内容Contents of the invention

本发明综合现有材料以及提高水凝胶性能的制备方法,提供一种术后防粘连水凝胶及其制备方法,将壳聚糖与海藻酸钠进行复合制备出高强度和高韧性的水凝胶,有望成为具有抗菌、止血、吸收组织渗出液、保持创面湿润和有效促进创面愈合的术后防粘连材料。The present invention integrates the existing materials and the preparation method for improving the performance of the hydrogel, and provides a postoperative anti-adhesion hydrogel and a preparation method thereof. Chitosan and sodium alginate are compounded to prepare a water gel with high strength and high toughness. Gel is expected to become a postoperative anti-adhesion material with antibacterial, hemostasis, absorption of tissue exudate, maintenance of wound surface moisture and effective promotion of wound healing.

本发明的目的是通过以下技术方案实现的:The purpose of the present invention is achieved through the following technical solutions:

一种术后防粘连水凝胶,由海藻酸钠粉末、壳聚糖粉末、丙烯酰胺单体、N,N’-亚甲基双丙烯酰胺、硫酸钙、过硫酸胺和N,N, N’ N’-四甲基乙二胺制备而成,其中,壳聚糖粉末与海藻酸钠粉末的质量比为8-10:1-3,壳聚糖和海藻酸钠混合粉末与丙烯酰胺单体的质量比为1:3-20,N,N’-亚甲基双丙烯酰与丙烯酰胺单体的质量比为0.0006-0.0025,硫酸钙与丙烯酰胺单体的质量比为0.016,过硫酸铵与丙烯酰胺单体的质量比为0.006-0.03,N,N,N’,N’-四甲基乙二胺与丙烯酰胺单体的质量比为0.0025-0.0055。A postoperative anti-adhesion hydrogel composed of sodium alginate powder, chitosan powder, acrylamide monomer, N,N'-methylenebisacrylamide, calcium sulfate, ammonium persulfate and N,N,N 'N'-tetramethylethylenediamine, wherein the mass ratio of chitosan powder to sodium alginate powder is 8-10:1-3, chitosan and sodium alginate mixed powder and acrylamide mono The mass ratio of the body is 1:3-20, the mass ratio of N,N'-methylenebisacryloyl to acrylamide monomer is 0.0006-0.0025, the mass ratio of calcium sulfate to acrylamide monomer is 0.016, persulfate The mass ratio of ammonium to acrylamide monomer is 0.006-0.03, and the mass ratio of N,N,N',N'-tetramethylethylenediamine to acrylamide monomer is 0.0025-0.0055.

一种上述术后防粘连水凝胶的制备方法,具体步骤如下:A preparation method of the above-mentioned postoperative anti-adhesion hydrogel, the specific steps are as follows:

第一步:在室温条件下将壳聚糖和海藻酸钠混合粉末溶解在0.5-2w/v%醋酸水溶液中,用磁力搅拌器搅拌使其充分溶解,得到均一稳定的混合溶液;Step 1: Dissolve chitosan and sodium alginate mixed powder in 0.5-2w/v% acetic acid aqueous solution at room temperature, stir with a magnetic stirrer to fully dissolve, and obtain a uniform and stable mixed solution;

第二步:依次向第一步得到的混合溶液中加入丙烯酰胺单体,将混合溶液在室温下搅拌10-48h直至溶液溶解均匀;然后逐步加入N,N’-亚甲基双丙烯酰胺、硫酸钙作为交联剂,过硫酸胺和N,N, N’ N’-四甲基乙二胺作为催化剂,在室温下继续搅拌0.5-3h,将配制好的溶液在室温下静置0.5-2h脱泡;将静置好的溶液倒入玻璃模具中,在室温下静置6-10h确保其完全反应,得到水凝胶。The second step: add acrylamide monomer to the mixed solution obtained in the first step in sequence, and stir the mixed solution at room temperature for 10-48 hours until the solution is uniformly dissolved; then gradually add N,N'-methylenebisacrylamide, Calcium sulfate is used as a crosslinking agent, ammonium persulfate and N,N,N' N'-tetramethylethylenediamine are used as catalysts, and stirring is continued at room temperature for 0.5-3h, and the prepared solution is left to stand at room temperature for 0.5- Degassing for 2 hours; Pour the static solution into a glass mold, and let it stand at room temperature for 6-10 hours to ensure its complete reaction to obtain a hydrogel.

第三步:将第二步制备好的水凝胶完全浸泡在浓度为0.05-1.5M的CaCl2溶液中3-36h,阳离子扩散进入水凝胶网络结构中,诱导壳聚糖和海藻酸钠交联,制备出高强高韧性的复合水凝胶防粘连材料。The third step: The hydrogel prepared in the second step is completely soaked in the CaCl 2 solution with a concentration of 0.05-1.5M for 3-36h, the cations diffuse into the hydrogel network structure, and induce chitosan and sodium alginate Cross-linking to prepare a high-strength and high-toughness composite hydrogel anti-adhesion material.

优选地,所述第一步溶液中壳聚糖与海藻酸钠混合粉末的浓度为0.5-2%(w/w)。Preferably, the concentration of chitosan and sodium alginate mixed powder in the first step solution is 0.5-2% (w/w).

优选地,所述第一步中壳聚糖为乳白色粉末,脱乙酰度>70%,级别为医用级,海藻酸钠为白色粉末,级别为医用级。Preferably, in the first step, chitosan is a milky white powder with a degree of deacetylation>70%, and its grade is medical grade, and sodium alginate is a white powder, and its grade is medical grade.

与现有技术相比,本发明的有益效果是:Compared with prior art, the beneficial effect of the present invention is:

1、本发明提供了一种高强、高韧性壳聚糖与海藻酸钠复合水凝胶的制备方法,该制备方法易于操作,参数可控,材料易得,溶剂无毒或低毒,处理和使用安全;该方法集结了两种天然生物材料的优点,能够很好的满足预防患者术后防粘连的要求,及医护人员的护理治疗需求。1. The present invention provides a preparation method of high-strength, high-toughness chitosan and sodium alginate composite hydrogel, the preparation method is easy to operate, the parameters are controllable, the material is easy to obtain, the solvent is non-toxic or low-toxic, and the treatment and It is safe to use; this method integrates the advantages of two natural biological materials, and can well meet the requirements of preventing postoperative anti-adhesion of patients and the nursing and treatment needs of medical staff.

2、该方法制备的壳聚糖与海藻酸钠复合水凝胶具有高强高韧性特点,弥补了以往水凝胶的不足,壳聚糖本身具有广谱抗菌、止血、吸收渗出液、愈创,以及良好的生物相容性和生物可降解性,海藻酸钠当与创面渗液接触时,可通过离子交换制备出可溶性的海藻酸钠,同时释放钙离子到伤口中,诱导血小板活化,可以加速创面愈合。2. The chitosan and sodium alginate composite hydrogel prepared by this method has the characteristics of high strength and high toughness, which makes up for the shortcomings of previous hydrogels. Chitosan itself has broad-spectrum antibacterial, hemostasis, absorption of exudate, healing , as well as good biocompatibility and biodegradability, when sodium alginate is in contact with wound exudate, soluble sodium alginate can be prepared by ion exchange, and at the same time release calcium ions into the wound to induce platelet activation, which can Accelerates wound healing.

3、该水凝胶柔软易于与皮肤贴合,具有良好的柔韧性,可以有效防止创面粘连,并能够被降解吸收,避免二次创伤的产生,有望成为新型术后防粘连材料。3. The hydrogel is soft and easy to adhere to the skin, has good flexibility, can effectively prevent wound adhesion, and can be degraded and absorbed to avoid secondary trauma. It is expected to become a new type of postoperative anti-adhesion material.

具体实施方式Detailed ways

下面结合实施例对本发明的技术方案作进一步的说明,但并不局限于此,凡是对本发明技术方案进行修改或者等同替换,而不脱离本发明技术方案的精神和范围,均应涵盖在本发明的保护范围中。The technical solution of the present invention will be further described below in conjunction with the examples, but it is not limited thereto. Any modification or equivalent replacement of the technical solution of the present invention without departing from the spirit and scope of the technical solution of the present invention should be covered by the present invention within the scope of protection.

实施例1Example 1

(1)用电子天平分别称取一定量的冰醋酸,配成质量分数为0.5w/v%的醋酸水溶液,称取一定质量CS/SA(9/1)粉末加入到醋酸水溶液中,配置成0.5w/v%的混合溶液,用磁力搅拌器搅拌使其充分溶解,得到均一稳定的溶液。(1) Weigh a certain amount of glacial acetic acid with an electronic balance to make an acetic acid aqueous solution with a mass fraction of 0.5w/v%, weigh a certain mass of CS/SA (9/1) powder and add it to the acetic acid aqueous solution to prepare The mixed solution of 0.5w/v% was stirred with a magnetic stirrer to fully dissolve it to obtain a uniform and stable solution.

(2)依次向上述混合溶液中加入丙烯酰胺单体,将混合溶液在室温下搅拌2d直至溶液溶解均匀;然后逐步加入N,N’-亚甲基双丙烯酰、硫酸钙作为交联剂,过硫酸胺和N,N,N’ N’-四甲基乙二胺作为催化剂,在室温下继续搅拌1h,将配制好的溶液在室温下静置0.5-2h脱泡;将静置好的溶液倒入玻璃模具中,在室温下静置一晚上确保其完全反应。其中:壳聚糖和海藻酸钠混合粉末与丙烯酰胺单体的质量比为1:5,N,N’-亚甲基双丙烯酰交联剂与丙烯酰胺单体的质量比为0.0006,硫酸钙与丙烯酰胺单体的质量比为0.016,过硫酸铵与丙烯酰胺单体的质量比为0.006,N,N,N’,N’-四甲基乙二胺与丙烯酰胺单体的质量比为0.0025。(2) Add acrylamide monomers to the above mixed solution in sequence, and stir the mixed solution at room temperature for 2 days until the solution is uniformly dissolved; then gradually add N,N'-methylenebisacryloyl and calcium sulfate as cross-linking agents, Use ammonium persulfate and N,N,N' N'-tetramethylethylenediamine as a catalyst, continue to stir at room temperature for 1h, and leave the prepared solution at room temperature for 0.5-2h to defoam; The solution was poured into glass molds and left overnight at room temperature to ensure complete reaction. Among them: the mass ratio of chitosan and sodium alginate mixed powder to acrylamide monomer is 1:5, the mass ratio of N,N'-methylenebisacryloyl crosslinking agent to acrylamide monomer is 0.0006, sulfuric acid The mass ratio of calcium to acrylamide monomer is 0.016, the mass ratio of ammonium persulfate to acrylamide monomer is 0.006, and the mass ratio of N,N,N',N'-tetramethylethylenediamine to acrylamide monomer is 0.0025.

(3)将制备好的水凝胶完全浸泡在浓度为0.5M的CaCl2溶液中12h,阳离子扩散进入水凝胶网络结构中,诱导壳聚糖和海藻酸钠交联,生产高强高韧性的复合水凝胶防粘连材料。(3) The prepared hydrogel was completely soaked in 0.5M CaCl 2 solution for 12 hours, the cations diffused into the hydrogel network structure, induced the cross-linking of chitosan and sodium alginate, and produced high strength and high toughness Composite hydrogel anti-adhesion material.

对制得的水凝胶进行拉伸测试,得到拉伸强度为995.3kPa;拉伸弹性模量200kPa。A tensile test was performed on the prepared hydrogel to obtain a tensile strength of 995.3 kPa; a tensile modulus of elasticity of 200 kPa.

实施例2Example 2

(1)用电子天平分别称取一定量的冰醋酸,配成质量分数为1w/v%的醋酸水溶液,称取一定质量CS/SA(10/2)粉末加入到醋酸水溶液中,配置成1w/v%的混合溶液,用磁力搅拌器搅拌使其充分溶解,得到均一稳定的溶液。(1) Weigh a certain amount of glacial acetic acid with an electronic balance to make an acetic acid aqueous solution with a mass fraction of 1w/v%, weigh a certain mass of CS/SA (10/2) powder and add it to the acetic acid aqueous solution to form a 1w /v% mixed solution, stir it with a magnetic stirrer to fully dissolve it, and obtain a uniform and stable solution.

(2)依次向上述混合溶液中加入丙烯酰胺单体,将混合溶液在室温下搅拌2d直至溶液溶解均匀;然后逐步加入N,N’-亚甲基双丙烯酰、硫酸钙作为交联剂,过硫酸胺和N,N,N’ N’-四甲基乙二胺作为催化剂,在室温下继续搅拌1h,将配制好的溶液在室温下静置0.5-2h脱泡;将静置好的溶液倒入玻璃模具中,在室温下静置一晚上确保其完全反应。其中:壳聚糖和海藻酸钠混合粉末与丙烯酰胺单体的质量比为1:7,N,N’-亚甲基双丙烯酰交联剂与丙烯酰胺单体的质量比为0.0010,硫酸钙与丙烯酰胺单体的质量比为0.016,过硫酸铵与丙烯酰胺单体的质量比为0.010,N,N,N’,N’-四甲基乙二胺与丙烯酰胺单体的质量比为0.0030。(2) Add acrylamide monomers to the above mixed solution in sequence, and stir the mixed solution at room temperature for 2 days until the solution is uniformly dissolved; then gradually add N,N'-methylenebisacryloyl and calcium sulfate as cross-linking agents, Use ammonium persulfate and N,N,N' N'-tetramethylethylenediamine as a catalyst, continue to stir at room temperature for 1h, and leave the prepared solution at room temperature for 0.5-2h to defoam; The solution was poured into glass molds and left overnight at room temperature to ensure complete reaction. Among them: the mass ratio of chitosan and sodium alginate mixed powder to acrylamide monomer is 1:7, the mass ratio of N,N'-methylenebisacryloyl crosslinking agent to acrylamide monomer is 0.0010, sulfuric acid The mass ratio of calcium to acrylamide monomer is 0.016, the mass ratio of ammonium persulfate to acrylamide monomer is 0.010, and the mass ratio of N,N,N',N'-tetramethylethylenediamine to acrylamide monomer is 0.0030.

(3)将制备好的水凝胶完全浸泡在浓度为0.5M的CaCl2溶液中12h,阳离子扩散进入水凝胶网络结构中,诱导壳聚糖和海藻酸钠交联,生产高强高韧性的复合水凝胶防粘连材料。(3) The prepared hydrogel was completely soaked in 0.5M CaCl 2 solution for 12 hours, the cations diffused into the hydrogel network structure, induced the cross-linking of chitosan and sodium alginate, and produced high strength and high toughness Composite hydrogel anti-adhesion material.

对制得的水凝胶进行拉伸测试,得到拉伸强度为999.8kPa;拉伸弹性模量285kPa。A tensile test was performed on the prepared hydrogel to obtain a tensile strength of 999.8 kPa; a tensile modulus of elasticity of 285 kPa.

实施例3Example 3

(1)用电子天平分别称取一定量的冰醋酸,配成质量分数为0.5w/v%的醋酸水溶液,称取一定质量CS/SA(9/3)粉末加入到醋酸水溶液中,配置成1w/v%的混合溶液,用磁力搅拌器搅拌使其充分溶解,得到均一稳定的溶液。(1) Weigh a certain amount of glacial acetic acid with an electronic balance to make an acetic acid aqueous solution with a mass fraction of 0.5w/v%, weigh a certain mass of CS/SA (9/3) powder and add it to the acetic acid aqueous solution to configure 1w/v% mixed solution, stirred with a magnetic stirrer to fully dissolve, to obtain a uniform and stable solution.

(2)依次向上述混合溶液中加入丙烯酰胺单体,将混合溶液在室温下搅拌2d直至溶液溶解均匀;然后逐步加入N,N’-亚甲基双丙烯酰、硫酸钙作为交联剂,过硫酸胺和N,N,N’ N’-四甲基乙二胺作为催化剂,在室温下继续搅拌1.5h,将配制好的溶液在室温下静置0.5-2h脱泡;将静置好的溶液倒入玻璃模具中,在室温下静置一晚上确保其完全反应。壳聚糖和海藻酸钠混合粉末与丙烯酰胺单体的质量比为1:8,N,N’-亚甲基双丙烯酰交联剂与丙烯酰胺单体的质量比为0.0012,硫酸钙与丙烯酰胺单体的质量比为0.016,过硫酸铵与丙烯酰胺单体的质量比为0.012,N,N,N’,N’-四甲基乙二胺与丙烯酰胺单体的质量比为0.0035。(2) Add acrylamide monomers to the above mixed solution in sequence, and stir the mixed solution at room temperature for 2 days until the solution is uniformly dissolved; then gradually add N,N'-methylenebisacryloyl and calcium sulfate as cross-linking agents, Use ammonium persulfate and N,N,N' N'-tetramethylethylenediamine as a catalyst, continue to stir at room temperature for 1.5h, and leave the prepared solution at room temperature for 0.5-2h to defoam; The solution was poured into glass molds and left overnight at room temperature to ensure complete reaction. The mass ratio of chitosan and sodium alginate mixed powder to acrylamide monomer is 1:8, the mass ratio of N,N'-methylenebisacryloyl crosslinking agent to acrylamide monomer is 0.0012, calcium sulfate and The mass ratio of acrylamide monomer is 0.016, the mass ratio of ammonium persulfate to acrylamide monomer is 0.012, and the mass ratio of N,N,N',N'-tetramethylethylenediamine to acrylamide monomer is 0.0035 .

(3)将制备好的水凝胶完全浸泡在浓度为1M的CaCl2溶液中12h,阳离子扩散进入水凝胶网络结构中,诱导壳聚糖和海藻酸钠交联,生产高强高韧性的复合水凝胶防粘连材料。(3) The prepared hydrogel was completely soaked in 1M CaCl 2 solution for 12 hours, the cations diffused into the hydrogel network structure, induced the cross-linking of chitosan and sodium alginate, and produced a high-strength and high-toughness composite Hydrogel anti-adhesion material.

对制得的水凝胶进行拉伸测试,得到拉伸强度为1166.5kPa;拉伸弹性模量190.5kPa。A tensile test was performed on the prepared hydrogel, and the tensile strength was 1166.5 kPa; the tensile elastic modulus was 190.5 kPa.

实施例4Example 4

(1)用电子天平分别称取一定量的冰醋酸,配成质量分数为1.5w/v%的醋酸水溶液,称取一定质量CS/SA(10/2)粉末加入到醋酸水溶液中,配置成1.5w/v%的混合溶液,用磁力搅拌器搅拌使其充分溶解,得到均一稳定的溶液。(1) Weigh a certain amount of glacial acetic acid with an electronic balance to make an acetic acid aqueous solution with a mass fraction of 1.5w/v%, weigh a certain mass of CS/SA (10/2) powder and add it to the acetic acid aqueous solution to prepare The mixed solution of 1.5w/v% was stirred with a magnetic stirrer to fully dissolve it to obtain a uniform and stable solution.

(2)依次向上述混合溶液中加入丙烯酰胺单体,将混合溶液在室温下搅拌2d直至溶液溶解均匀;然后逐步加入N,N’-亚甲基双丙烯酰、硫酸钙作为交联剂,过硫酸胺和N,N,N’ N’-四甲基乙二胺作为催化剂,在室温下继续搅拌1.5h,将配制好的溶液在室温下静置0.5-2h脱泡;将静置好的溶液倒入玻璃模具中,在室温下静置一晚上确保其完全反应。其中:壳聚糖和海藻酸钠混合粉末与丙烯酰胺单体的质量比为1:10,N,N’-亚甲基双丙烯酰交联剂与丙烯酰胺单体的质量比为0.0018,硫酸钙与丙烯酰胺单体的质量比为0.016,过硫酸铵与丙烯酰胺单体的质量比为0.018,N,N,N’,N’-四甲基乙二胺与丙烯酰胺单体的质量比为0.0025。(2) Add acrylamide monomers to the above mixed solution in sequence, and stir the mixed solution at room temperature for 2 days until the solution is uniformly dissolved; then gradually add N,N'-methylenebisacryloyl and calcium sulfate as cross-linking agents, Use ammonium persulfate and N,N,N' N'-tetramethylethylenediamine as a catalyst, continue to stir at room temperature for 1.5h, and leave the prepared solution at room temperature for 0.5-2h to defoam; The solution was poured into glass molds and left overnight at room temperature to ensure complete reaction. Among them: the mass ratio of chitosan and sodium alginate mixed powder to acrylamide monomer is 1:10, the mass ratio of N,N'-methylenebisacryloyl crosslinking agent to acrylamide monomer is 0.0018, sulfuric acid The mass ratio of calcium to acrylamide monomer is 0.016, the mass ratio of ammonium persulfate to acrylamide monomer is 0.018, and the mass ratio of N,N,N',N'-tetramethylethylenediamine to acrylamide monomer is 0.0025.

(3)将制备好的水凝胶完全浸泡在浓度为1M的CaCl2溶液中12h,阳离子扩散进入水凝胶网络结构中,诱导壳聚糖和海藻酸钠交联,生产高强高韧性的复合水凝胶防粘连材料。(3) The prepared hydrogel was completely soaked in 1M CaCl 2 solution for 12 hours, the cations diffused into the hydrogel network structure, induced the cross-linking of chitosan and sodium alginate, and produced a high-strength and high-toughness composite Hydrogel anti-adhesion material.

对制得的水凝胶进行拉伸测试,得到拉伸强度为736.5kPa;拉伸弹性模量68.5kPa。A tensile test was performed on the prepared hydrogel, and the tensile strength was 736.5 kPa; the tensile elastic modulus was 68.5 kPa.

实施例5Example 5

(1)用电子天平分别称取一定量的冰醋酸,配成质量分数为2w/v%的醋酸水溶液,称取一定质量CS/SA (8/3)粉末加入到醋酸水溶液中,配置成2w/v%的混合溶液,用磁力搅拌器搅拌使其充分溶解,得到均一稳定的溶液。(1) Weigh a certain amount of glacial acetic acid with an electronic balance to make an acetic acid aqueous solution with a mass fraction of 2w/v%, weigh a certain mass of CS/SA (8/3) powder and add it to the acetic acid aqueous solution to form a 2w /v% mixed solution, stir it with a magnetic stirrer to fully dissolve it, and obtain a uniform and stable solution.

(2)依次向上述混合溶液中加入丙烯酰胺单体,将混合溶液在室温下搅拌2d直至溶液溶解均匀;然后逐步加入N,N’-亚甲基双丙烯酰、硫酸钙作为交联剂,过硫酸胺和N,N,N’ N’-四甲基乙二胺作为催化剂,在室温下继续搅拌2h,将配制好的溶液在室温下静置0.5-2h脱泡;将静置好的溶液倒入玻璃模具中,在室温下静置一晚上确保其完全反应。其中:壳聚糖和海藻酸钠混合粉末与丙烯酰胺单体的质量比为1:10,N,N’-亚甲基双丙烯酰交联剂与丙烯酰胺单体的质量比为0.0025,硫酸钙与丙烯酰胺单体的质量比为0.016,过硫酸铵与丙烯酰胺单体的质量比为0.025,N,N,N’,N’-四甲基乙二胺与丙烯酰胺单体的质量比为0.0055。(2) Add acrylamide monomers to the above mixed solution in sequence, and stir the mixed solution at room temperature for 2 days until the solution is uniformly dissolved; then gradually add N,N'-methylenebisacryloyl and calcium sulfate as cross-linking agents, Use ammonium persulfate and N,N,N' N'-tetramethylethylenediamine as a catalyst, continue to stir at room temperature for 2h, and leave the prepared solution at room temperature for 0.5-2h to defoam; The solution was poured into glass molds and left overnight at room temperature to ensure complete reaction. Among them: the mass ratio of chitosan and sodium alginate mixed powder to acrylamide monomer is 1:10, the mass ratio of N,N'-methylenebisacryloyl crosslinking agent to acrylamide monomer is 0.0025, sulfuric acid The mass ratio of calcium to acrylamide monomer is 0.016, the mass ratio of ammonium persulfate to acrylamide monomer is 0.025, and the mass ratio of N,N,N',N'-tetramethylethylenediamine to acrylamide monomer is 0.0055.

(3)将制备好的水凝胶完全浸泡在浓度为1M的CaCl2溶液中24h,阳离子扩散进入水凝胶网络结构中,诱导壳聚糖和海藻酸钠交联,生产高强高韧性的复合水凝胶防粘连材料。(3) The prepared hydrogel was completely immersed in 1M CaCl 2 solution for 24 hours, the cations diffused into the hydrogel network structure, induced the cross-linking of chitosan and sodium alginate, and produced a composite with high strength and high toughness. Hydrogel anti-adhesion material.

对制得的水凝胶进行拉伸测试,得到拉伸强度为683.7kPa;拉伸弹性模量78.7kPa。A tensile test was performed on the prepared hydrogel, and the tensile strength was 683.7kPa; the tensile elastic modulus was 78.7kPa.

以上实施例中所用的壳聚糖(CS)为乳白色粉末,脱乙酰度>70%,级别为医用级。所述的海藻酸钠(SA)为白色粉末,级别为医用级。Chitosan (CS) used in the above examples is a milky white powder with a degree of deacetylation>70%, and the grade is medical grade. Described sodium alginate (SA) is white powder, grade is medical grade.

Claims (10)

1. a kind of post-operation adhesion preventing hydrogel, it is characterised in that the hydrogel is by sodium alginate powder, Chitosan powder, propylene Amide monomer, N, N '-methylene-bisacrylamide, calcium sulfate, Ammonium Persulfate 98.5 and N, N, N ' N '-tetramethylethylenediamine prepare and Into, wherein, the mass ratio of Chitosan powder and sodium alginate powder is 8-10:1-3, chitosan and sodium alginate mixed-powder with The mass ratio of acrylamide monomer is 1:The mass ratio of 3-20, N, N '-methylene-bisacrylamide and acrylamide monomer is The mass ratio of 0.0006-0.0025, calcium sulfate and acrylamide monomer is 0.016, the matter of ammonium persulfate and acrylamide monomer Amount is than being 0.006-0.03, N, N, N ', the mass ratio of N '-tetramethylethylenediamine and acrylamide monomer is 0.0025-0.0055.
2. post-operation adhesion preventing hydrogel according to claim 1, it is characterised in that the Chitosan powder and sodium alginate The mass ratio of powder is 9:1, chitosan and the mass ratio of sodium alginate mixed-powder and acrylamide monomer are 1:5, N, N '-sub- The mass ratio of bisacrylamide and acrylamide monomer is 0.0006, and the mass ratio of calcium sulfate and acrylamide monomer is 0.016, the mass ratio of ammonium persulfate and acrylamide monomer is 0.006, N, N, N ', N '-tetramethylethylenediamine and acrylamide The mass ratio of monomer is 0.0025.
3. post-operation adhesion preventing hydrogel according to claim 1, it is characterised in that the Chitosan powder and sodium alginate The mass ratio of powder is 10:2, chitosan and the mass ratio of sodium alginate mixed-powder and acrylamide monomer are 1:7, N, N '- The mass ratio of methylene-bisacrylamide and acrylamide monomer is 0.0010, and the mass ratio of calcium sulfate and acrylamide monomer is 0.016, the mass ratio of ammonium persulfate and acrylamide monomer is 0.010, N, N, N ', N '-tetramethylethylenediamine and acrylamide The mass ratio of monomer is 0.0030.
4. post-operation adhesion preventing hydrogel according to claim 1, it is characterised in that the Chitosan powder and sodium alginate The mass ratio of powder is 9:3, chitosan and the mass ratio of sodium alginate mixed-powder and acrylamide monomer are 1:8, N, N '-sub- The mass ratio of bisacrylamide and acrylamide monomer is 0.0012, and the mass ratio of calcium sulfate and acrylamide monomer is 0.016, the mass ratio of ammonium persulfate and acrylamide monomer is 0.012, N, N, N ', N '-tetramethylethylenediamine and acrylamide The mass ratio of monomer is 0.0035.
5. post-operation adhesion preventing hydrogel according to claim 1, it is characterised in that the Chitosan powder and sodium alginate The mass ratio of powder is 10:2, chitosan and the mass ratio of sodium alginate mixed-powder and acrylamide monomer are 1:10, N, N '- The mass ratio of methylene-bisacrylamide and acrylamide monomer is 0.0018, and the mass ratio of calcium sulfate and acrylamide monomer is 0.016, the mass ratio of ammonium persulfate and acrylamide monomer is 0.018, N, N, N ', N '-tetramethylethylenediamine and acrylamide The mass ratio of monomer is 0.0025.
6. post-operation adhesion preventing hydrogel according to claim 1, it is characterised in that the Chitosan powder and sodium alginate The mass ratio of powder is 8:3, chitosan and the mass ratio of sodium alginate mixed-powder and acrylamide monomer are 1:10, N, N '- The mass ratio of methylene-bisacrylamide and acrylamide monomer is 0.0025, and the mass ratio of calcium sulfate and acrylamide monomer is 0.016, the mass ratio of ammonium persulfate and acrylamide monomer is 0.025, N, N, N ', N '-tetramethylethylenediamine and acrylamide The mass ratio of monomer is 0.0055.
7. according to the post-operation adhesion preventing hydrogel described in claim 1,2,3,4,5 or 6, it is characterised in that the chitosan is breast White powder, deacetylation>70%, rank is medical grade;Sodium alginate is white powder, and rank is medical grade.
8. a kind of preparation method of the post-operation adhesion preventing hydrogel described in claim 1-6 any claims, it is characterised in that The method step is as follows:
The first step:Chitosan and sodium alginate mixed-powder are dissolved in aqueous acetic acid at ambient temperature, stirred with magnetic force Mixing device stirring makes it fully dissolve, and obtains the mixed solution of stable homogeneous;
Second step:Acrylamide monomer is added in into the mixed solution that the first step obtains successively, mixed solution is stirred at room temperature 10-48h is mixed until solution is uniformly dissolved;Be then gradually adding N, N '-methylene-bisacrylamide, calcium sulfate as crosslinking agent, Ammonium Persulfate 98.5 and N, N, N ' N '-tetramethylethylenediamine continues to stir 0.5-3h at room temperature as catalyst, will be prepared molten Liquid stands 0.5-2h deaerations at room temperature;The solution stood is poured into glass mold, standing 6-10h at room temperature ensures it Reaction completely, obtains hydrogel;
Third walks:The hydrogel that second step prepares is fully immersed in the CaCl of a concentration of 0.05-1.5M23-36h in solution, Cation is diffused into hydrogel network structure, is induced chitosan and sodium alginate cross-linking, is prepared answering for high-strength and high-ductility Heshui gel adherence preventing material.
9. the preparation method of post-operation adhesion preventing hydrogel according to claim 8, it is characterised in that the first step acetic acid A concentration of 0.5-2w/v% of aqueous solution, a concentration of 0.5-2% of chitosan and sodium alginate mixed-powder in mixed solution(w/ w).
10. the preparation method of post-operation adhesion preventing hydrogel according to claim 8, it is characterised in that shell in the first step Glycan is off-white powder, deacetylation>70%, rank is medical grade, and sodium alginate is white powder, and rank is medical grade.
CN201510598128.7A 2015-09-20 2015-09-20 A kind of post-operation adhesion preventing hydrogel and preparation method thereof Expired - Fee Related CN105194740B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201510598128.7A CN105194740B (en) 2015-09-20 2015-09-20 A kind of post-operation adhesion preventing hydrogel and preparation method thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201510598128.7A CN105194740B (en) 2015-09-20 2015-09-20 A kind of post-operation adhesion preventing hydrogel and preparation method thereof

Publications (2)

Publication Number Publication Date
CN105194740A CN105194740A (en) 2015-12-30
CN105194740B true CN105194740B (en) 2018-06-26

Family

ID=54942912

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201510598128.7A Expired - Fee Related CN105194740B (en) 2015-09-20 2015-09-20 A kind of post-operation adhesion preventing hydrogel and preparation method thereof

Country Status (1)

Country Link
CN (1) CN105194740B (en)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3064403C (en) 2010-10-01 2022-06-21 Applied Medical Resources Corporation Portable laparoscopic trainer
US9218753B2 (en) 2011-10-21 2015-12-22 Applied Medical Resources Corporation Simulated tissue structure for surgical training
JP2015503961A (en) 2011-12-20 2015-02-05 アプライド メディカル リソーシーズ コーポレイション Advanced surgery simulation
EP2907125B1 (en) 2012-09-26 2017-08-02 Applied Medical Resources Corporation Surgical training model for laparoscopic procedures
US10679520B2 (en) 2012-09-27 2020-06-09 Applied Medical Resources Corporation Surgical training model for laparoscopic procedures
CA2885302C (en) 2012-09-27 2022-08-02 Applied Medical Resources Corporation Surgical training model for laparoscopic procedures
KR102537277B1 (en) 2013-03-01 2023-05-30 어플라이드 메디컬 리소시스 코포레이션 Advanced surgical simulation constructions and methods
EP4170633A1 (en) 2013-06-18 2023-04-26 Applied Medical Resources Corporation Gallbladder model
US10198966B2 (en) 2013-07-24 2019-02-05 Applied Medical Resources Corporation Advanced first entry model for surgical simulation
EP3410421A1 (en) 2013-07-24 2018-12-05 Applied Medical Resources Corporation First entry model
EP3123460B1 (en) 2014-03-26 2021-08-25 Applied Medical Resources Corporation Simulated dissectible tissue
KR102615540B1 (en) 2014-11-13 2023-12-19 어플라이드 메디컬 리소시스 코포레이션 Simulated tissue models and methods
ES2732722T3 (en) 2015-02-19 2019-11-25 Applied Med Resources Simulated tissue structures and methods
AU2016260331A1 (en) 2015-05-14 2017-08-17 Applied Medical Resources Corporation Synthetic tissue structures for electrosurgical training and simulation
ES2925028T3 (en) 2015-06-09 2022-10-13 Applied Med Resources hysterectomy model
EP3748610A1 (en) 2015-07-16 2020-12-09 Applied Medical Resources Corporation Simulated dissectable tissue
JP6862413B2 (en) 2015-07-22 2021-04-21 アプライド メディカル リソーシーズ コーポレイション Appendectomy model
ES2962620T3 (en) 2015-10-02 2024-03-20 Applied Med Resources Hysterectomy model
KR102757131B1 (en) 2015-11-20 2025-01-20 어플라이드 메디컬 리소시스 코포레이션 Simulated exciseable tissue
CA3028980A1 (en) 2016-06-27 2018-01-04 Applied Medical Resources Corporaton Simulated abdominal wall
WO2018152122A1 (en) 2017-02-14 2018-08-23 Applied Medical Resources Corporation Laparoscopic training system
US10847057B2 (en) 2017-02-23 2020-11-24 Applied Medical Resources Corporation Synthetic tissue structures for electrosurgical training and simulation
US11623029B2 (en) * 2017-04-06 2023-04-11 Luna Labs Usa, Llc Sprayable barrier and methods for prevention of postoperative adhesions
CN107519541B (en) * 2017-08-21 2021-01-01 上海鹏冠生物医药科技有限公司 Hydrogel for preventing postoperative adhesion of abdominal cavity and preparation method and application thereof
CN109394734A (en) * 2018-09-11 2019-03-01 杭州美善明康生物科技有限责任公司 Except the preparation method of the solid skin sticker of scar
CN109675092B (en) * 2018-12-17 2021-09-10 西北工业大学 Multifunctional hydrogel adhesive suitable for high-strength bonding of dynamic tissue surface and preparation method thereof
CN109701088B (en) * 2018-12-19 2021-12-21 广州润虹医药科技股份有限公司 Antibacterial and anti-inflammatory hernia repair patch and preparation method thereof
CN111481735A (en) * 2019-01-25 2020-08-04 华中科技大学同济医学院附属协和医院 Medical antibacterial wound-protecting hydrogel dressing and preparation method thereof
CN110448727B (en) * 2019-09-17 2021-10-19 南通大学 A kind of viscous hydrogel material, suture-free artificial nerve conduit and preparation method thereof
CN111729123A (en) * 2020-06-29 2020-10-02 苏州凝智新材料发展有限公司 Suture-free hydrogel adhesive plaster for tissue wound closure and preparation method thereof
CN112316219B (en) * 2020-09-29 2022-05-10 浙江大学 An anti-adhesion hydrogel-silk scaffold composite membrane and its preparation and application
CN113491794A (en) * 2021-04-16 2021-10-12 中国医学科学院北京协和医院 Hydrogel patch for repairing dura mater spinalis defect and preparation method and application thereof
CN113563534B (en) * 2021-08-12 2022-11-15 深圳市第二人民医院(深圳市转化医学研究院) A kind of composite polyacrylamide gel and its preparation method and application
CN113577400B (en) * 2021-08-16 2022-08-02 青岛琛蓝海洋生物工程有限公司 Preparation method of marine plant polysaccharide anti-adhesion material
CN114209891B (en) * 2021-12-17 2023-02-28 福州大学 A kind of super lubricating hydrogel coating of wet state adhesion and preparation method thereof
CN115245812A (en) * 2022-01-02 2022-10-28 华东理工大学 Preparation method of chitosan/sodium alginate/acrylamide composite hydrogel

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103224679A (en) * 2013-05-09 2013-07-31 重庆大学 Chitosan polyacrylamide hydrogel base material and preparation method thereof
CN103396562A (en) * 2013-07-09 2013-11-20 西安交通大学 Preparation method for sodium alginate-acrylamide-based hydrogel
CN103469365A (en) * 2013-09-22 2013-12-25 山东颐诺生物科技有限公司 Alginic acid-chitosan composite fiber for tranma repairing and preparation method thereof
CN104874029A (en) * 2015-03-30 2015-09-02 陕西佰傲再生医学有限公司 Hemostatic non-viscous material and preparation method thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101360942B1 (en) * 2012-10-08 2014-02-12 조선대학교산학협력단 Cell-laden biocompatible polymer-natural biocompatible material hybrid scaffold and producing method therof

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103224679A (en) * 2013-05-09 2013-07-31 重庆大学 Chitosan polyacrylamide hydrogel base material and preparation method thereof
CN103396562A (en) * 2013-07-09 2013-11-20 西安交通大学 Preparation method for sodium alginate-acrylamide-based hydrogel
CN103469365A (en) * 2013-09-22 2013-12-25 山东颐诺生物科技有限公司 Alginic acid-chitosan composite fiber for tranma repairing and preparation method thereof
CN104874029A (en) * 2015-03-30 2015-09-02 陕西佰傲再生医学有限公司 Hemostatic non-viscous material and preparation method thereof

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
海藻酸钠/壳聚糖复合凝胶的制备与细胞毒性评价;张林朴等;《中国组织工程研究》;20140521;第18卷(第21期);摘要、第3311页左栏第1段至第3314页右栏第3段 *

Also Published As

Publication number Publication date
CN105194740A (en) 2015-12-30

Similar Documents

Publication Publication Date Title
CN105194740B (en) A kind of post-operation adhesion preventing hydrogel and preparation method thereof
Liu et al. A highly-stretchable and adhesive hydrogel for noninvasive joint wound closure driven by hydrogen bonds
Chen et al. Antibacterial adhesive self-healing hydrogels to promote diabetic wound healing
KR102469682B1 (en) Formulation for repairing biological damage or hemostasis and method therefor
CN108912352A (en) A kind of antibacterial adherency injection aquagel dressing and its preparation method and application
US9642933B2 (en) Compositions comprising bioadhesives and methods of making the same
Liu et al. Ultra-stretchable, tissue-adhesive, shape-adaptive, self-healing, on-demand removable hydrogel dressings with multiple functions for infected wound healing in regions of high mobility
CN108976317A (en) A kind of chitosan biological macromolecular and its preparation method and application
WO2007103208A2 (en) Biodegradable foam
ES2875098T3 (en) High efficiency hemostatic adhesive polymer scaffold
CN109529101B (en) Rapidly degradable strong and tough hydrogel wound dressing and preparation method thereof
CN113368312B (en) Preparation method and application of biodegradable self-adhesive hydrogel
Cao et al. Photo-crosslinked enhanced double-network hydrogels based on modified gelatin and oxidized sodium alginate for diabetic wound healing
CN112023109B (en) Self-repairing hemostatic film capable of being adhered and preparation method thereof
CN102580134A (en) Biological and haemostatic wound dressing and preparation method thereof
CN112007200B (en) Antibacterial repair-promoting hemostatic anti-adhesion membrane and preparation method thereof
Zhang et al. A self-healing hydrogel wound dressing based on oxidized Bletilla striata polysaccharide and cationic gelatin for skin trauma treatment
CN104888265B (en) The preparation method of temperature sensitive type collagen-based compound hemostatic gel
CN107261195B (en) Preparation method and application of antibacterial biomass gel net for sports wound rehabilitation dressing
JP6437087B2 (en) Heat-sensitive adhesion preventing composition and use thereof
CN112876597B (en) A kind of cross-linking agent, bioadhesive and its preparation method and application
Zhang et al. Self-healing, antioxidant, and antibacterial Bletilla striata polysaccharide-tannic acid dual dynamic crosslinked hydrogels for tissue adhesion and rapid hemostasis
Xu et al. Engineering air-in-water emulsion as adaptable multifunctional sealant
CN112007201B (en) Adhesive antibacterial hemostatic sponge and preparation method thereof
CN118203694A (en) Recombinant humanized collagen gel with stable cell adhesion

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
CB03 Change of inventor or designer information

Inventor after: He Jinmei

Inventor after: Cheng Feng

Inventor after: Li Hongbin

Inventor after: Huang Yudong

Inventor after: Liu Changyu

Inventor after: Li Jiwei

Inventor before: He Jinmei

Inventor before: Cheng Feng

Inventor before: Liu Changyu

Inventor before: Li Jiwei

Inventor before: Huang Yudong

CB03 Change of inventor or designer information
GR01 Patent grant
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20180626

CF01 Termination of patent right due to non-payment of annual fee